GL1X · GenesisL1 explorer

Ligand · 9XX

9XX · (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate

9XX, (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate (C38 H74 O4, 595.0 g/mol), in the MolNFT structures on GenesisL1: bound in 5 records (5 PDB entries). Every binding site with its residues within 4.5 Å, the residues it…

Component
9XX
Formula
C38 H74 O4
Class
ligand
Structures
5
PDB entries
5

Binding sites

9XX in 5 structures; the first of them:

  • 6ADQ · Respiratory complex CIII2CIV2SOD2 from mycobacterium smegmatis · 9XX Y302 · binds CYS21, PHE320, TYR321, VAL331, TRP332
  • 7Q21 · III2-IV2 respiratory supercomplex from corynebacterium glutamicum · 9XX H202 · binds VAL59, ILE62, TRP63, VAL66, LEU70, PHE141, LEU142, CYS27
  • 7RH5 · Mycobacterial CIII2CIV2 supercomplex, inhibitor free · 9XX D302 · binds PHE320, TYR321, PRO322, ILE327, TRP332, VAL335, CYS21
  • 7RH6 · Mycobacterial CIII2CIV2 supercomplex, inhibitor free, -lpqe cyt cc open · 9XX D302 · binds PHE320, TYR321, PRO322, ILE327, TRP332, VAL335, CYS21
  • 7RH7 · Mycobacterial CIII2CIV2 supercomplex, telacebec (Q203) bound · 9XX W201 · binds CYS24, LEU134, ILE137, ALA138, PHE140, ILE141, VAL71, PHE79 and 1 more

Residues it binds most

PHE 19, VAL 17, CYS 19, ILE 12, TRP 14, LEU 10, TYR 8, PRO 6, ALA 5, MET 2 (residue and the binding sites it lines).

Found with

  • 9YF · (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1r,2r,3r,4r, 5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate
  • CDL · Cardiolipin
  • FES · Fe2/s2 (inorganic) cluster
  • HEC · Heme C
  • HEM · Protoporphyrin IX containing Fe
  • MQ9 · Menaquinone-9
  • PLM · Palmitic acid
  • CU · Copper (II) ion
  • 9Y0 · (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate
  • HEA · Heme-A
  • 7PH · (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate
  • HAS · Heme-as

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.